MedPath

Rivaroxaban, heparin and enoxaparin as thromboprophylaxis agents for gynecology oncologic surgery

Phase 3
Recruiting
Conditions
Condition 1: Venous thromboembolism. Condition 2: Pulmonary embolism.
Other venous embolism and thrombosis
Pulmonary embolism
Registration Number
IRCT20151020024625N19
Lead Sponsor
Semnan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
90
Inclusion Criteria

Candidates for gynecologic oncologic surgery

Exclusion Criteria

Receiving anticoagulants agents at present
Contraindication for anticoagulants
Uncontrolled cardiovascular and cerebrovascular diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.